Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel C. Nussenzweig is active.

Publication


Featured researches published by Michel C. Nussenzweig.


Cell | 2004

AID Is Required for c-myc/IgH Chromosome Translocations In Vivo

Almudena R. Ramiro; Mila Jankovic; Thomas R. Eisenreich; Simone Difilippantonio; Selina Chen-Kiang; Masamichi Muramatsu; Tasuku Honjo; André Nussenzweig; Michel C. Nussenzweig

Chromosome translocations between c-myc and immunoglobulin (Ig) are associated with Burkitts lymphoma in humans and with pristane- and IL6-induced plasmacytomas in mice. These translocations frequently involve Ig switch regions, suggesting that they might be the result of aberrant Ig class switch recombination (CSR). However, a direct link between CSR and chromosome translocations has not been established. We have examined c-myc/IgH translocations in IL6 transgenic mice that are mutant for activation induced cytidine deaminase (AID), the enzyme that initiates CSR. Here we report that AID is essential for the c-myc/IgH chromosome translocations induced by IL6.


Nature | 2008

53BP1 facilitates long-range DNA end-joining during V(D)J recombination.

Simone Difilippantonio; Eric J. Gapud; Nancy Wong; Ching-Yu Huang; Grace K. Mahowald; Hua Tang Chen; Michael J. Kruhlak; Elsa Callen; Ferenc Livak; Michel C. Nussenzweig; Barry P. Sleckman; André Nussenzweig

Variable, diversity and joining (V(D)J) recombination and class-switch recombination use overlapping but distinct non-homologous end joining pathways to repair DNA double-strand-break intermediates. 53BP1 is a DNA-damage-response protein that is rapidly recruited to sites of chromosomal double-strand breaks, where it seems to function in a subset of ataxia telangiectasia mutated (ATM) kinase-, H2A histone family member X (H2AX, also known as H2AFX)- and mediator of DNA damage checkpoint 1 (MDC1)-dependent events. A 53BP1-dependent end-joining pathway has been described that is dispensable for V(D)J recombination but essential for class-switch recombination. Here we report a previously unrecognized defect in the joining phase of V(D)J recombination in 53BP1-deficient lymphocytes that is distinct from that found in classical non-homologous-end-joining-, H2ax-, Mdc1- and Atm-deficient mice. Absence of 53BP1 leads to impairment of distal V–DJ joining with extensive degradation of unrepaired coding ends and episomal signal joint reintegration at V(D)J junctions. This results in apoptosis, loss of T-cell receptor α locus integrity and lymphopenia. Further impairment of the apoptotic checkpoint causes propagation of lymphocytes that have antigen receptor breaks. These data suggest a more general role for 53BP1 in maintaining genomic stability during long-range joining of DNA breaks.


Cell | 2010

Origin of Chromosomal Translocations in Lymphoid Cancer

André Nussenzweig; Michel C. Nussenzweig

Aberrant fusions between heterologous chromosomes are among the most prevalent cytogenetic abnormalities found in cancer cells. Oncogenic chromosomal translocations provide cells with a proliferative or survival advantage. They may either initiate transformation or be acquired secondarily as a result of genomic instability. Here, we highlight recent advances toward understanding the origin of chromosomal translocations in incipient lymphoid cancers and how tumor-suppressive pathways normally limit the frequency of these aberrant recombination events. Deciphering the mechanisms that mediate chromosomal fusions will open new avenues for developing therapeutic strategies aimed at eliminating lesions that lead to the initiation, maintenance, and progression of cancer.


Science | 2002

Genomic Instability in Mice Lacking Histone H2AX

Arkady Celeste; Simone Petersen; Peter J. Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A. Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J. Difilippantonio; Christophe E. Redon; Duane R. Pilch; Alexandru Olaru; Michael Eckhaus; R. Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M. Bonner; Michel C. Nussenzweig; André Nussenzweig


Annual Review of Immunology | 2004

RAGs and Regulation of Autoantibodies

Mila Jankovic; Rafael Casellas; Nikos Yannoutsos; Hedda Wardemann; Michel C. Nussenzweig


Archive | 2012

ANTI-HIV ANTIBODIES HAVING INCREASED POTENCY AND BREADTH

Ron Diskin; Pamela J. Bjorkman; Michel C. Nussenzweig; Johannes Scheid


Archive | 2013

Broadly-neutralizing anti-hiv antibodies

Hugo Mouquet; Michel C. Nussenzweig; Pamela J. Bjorkman; Louise Scharf


Archive | 2012

Human immunodeficiency virus neutralizing antibodies adn methods of use thereof

Johannes Scheid; Michel C. Nussenzweig; Pamela J. Bjorkman; Ron Diskin


Archive | 2013

ANTIBODIES TARGETING HIV ESCAPE MUTANTS

Ron Diskin; Anthony P. West; Michel C. Nussenzweig; Pamela J. Bjorkman


Archive | 2012

Compositions and methods for improving potency and breadth or hiv antibodies

Ron Diskin; Pamela J. Bjorkman; Michel C. Nussenzweig; Johannes Scheid

Collaboration


Dive into the Michel C. Nussenzweig's collaboration.

Top Co-Authors

Avatar

Pamela J. Bjorkman

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ron Diskin

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

André Nussenzweig

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Johannes Scheid

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Anthony P. West

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hua Tang Chen

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge